IMpower150: Efficacy of atezolizumab (atezo) plus bevacizumab (bev) and chemotherapy (chemo) in 1L metastatic nonsquamous NSCLC (mNSCLC) across key subgroups Meeting Abstract

Industry Collaboration International Collaboration

cited authors

  • Kowanetz, Marcin; Socinski, Mark A.; Zou, Wei; McCleland, Mark; Yang, Nancy; Chavez, Ariel Lopez; Spira, Alexander; Mazieres, Julien; Braiteh, Fadi; Shames, David; Sandler, Alan; Reck, Martin

authors

Publication Date

  • July 1, 2018

webpage

published in

category

volume

  • 78

issue

  • 13